[Immunological profile of high-risk patients treated with different types of immunosuppressive therapy].
Molajoni
E R
ER
Cinti
P
P
Bachetoni
A
A
Sallusto
F
F
Orlandini
A
A
Alfani
D
D
Cortesini
R
R
D000961:Antilymphocyte Serum; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000008:administration & dosage / Q000494:pharmacology; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology; D016030:Kidney Transplantation; D008221:Lymphoid Tissue / Q000528:radiation effects; D015122:Mercaptopurine / Q000008:administration & dosage / Q000494:pharmacology; D012306:Risk
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D015122:Mercaptopurine
Profilo immunologico di pazienti ad alto rischio trattati con diversi modelli di terapia immunosoppressiva.